GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (FRA:AG8) » Definitions » Cyclically Adjusted Price-to-FCF

Agilent Technologies (FRA:AG8) Cyclically Adjusted Price-to-FCF : 44.98 (As of May. 22, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Agilent Technologies's current share price is €141.70. Agilent Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 was €3.15. Agilent Technologies's Cyclically Adjusted Price-to-FCF for today is 44.98.

The historical rank and industry rank for Agilent Technologies's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:AG8' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 16.44   Med: 30.83   Max: 64.26
Current: 46.61

During the past years, Agilent Technologies's highest Cyclically Adjusted Price-to-FCF was 64.26. The lowest was 16.44. And the median was 30.83.

FRA:AG8's Cyclically Adjusted Price-to-FCF is ranked worse than
67.74% of 62 companies
in the Medical Diagnostics & Research industry
Industry Median: 37.035 vs FRA:AG8: 46.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Agilent Technologies's adjusted free cash flow per share data for the three months ended in Jan. 2024 was €1.233. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €3.15 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Agilent Technologies Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Agilent Technologies's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Cyclically Adjusted Price-to-FCF Chart

Agilent Technologies Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.46 39.66 56.31 46.40 32.17

Agilent Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.72 44.30 38.27 32.17 39.46

Competitive Comparison of Agilent Technologies's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Agilent Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Cyclically Adjusted Price-to-FCF falls into.



Agilent Technologies Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Agilent Technologies's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=141.70/3.15
=44.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilent Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Agilent Technologies's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=1.233/130.1244*130.1244
=1.233

Current CPI (Jan. 2024) = 130.1244.

Agilent Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.584 100.023 0.760
201407 -0.079 100.520 -0.102
201410 0.329 100.176 0.427
201501 -0.132 98.604 -0.174
201504 0.447 99.824 0.583
201507 0.242 100.691 0.313
201510 0.574 100.346 0.744
201601 0.203 99.957 0.264
201604 0.615 100.947 0.793
201607 0.469 101.524 0.601
201610 0.502 101.988 0.640
201701 0.242 102.456 0.307
201704 0.614 103.167 0.774
201707 0.492 103.278 0.620
201710 0.595 104.070 0.744
201801 0.393 104.578 0.489
201804 0.638 105.708 0.785
201807 0.433 106.324 0.530
201810 0.908 106.695 1.107
201901 0.473 106.200 0.580
201904 0.591 107.818 0.713
201907 0.548 108.250 0.659
201910 0.823 108.577 0.986
202001 -0.268 108.841 -0.320
202004 0.826 108.173 0.994
202007 0.739 109.318 0.880
202010 0.954 109.861 1.130
202101 0.523 110.364 0.617
202104 1.201 112.673 1.387
202107 0.774 115.183 0.874
202110 1.064 116.696 1.186
202201 0.525 118.619 0.576
202204 0.674 121.978 0.719
202207 0.802 125.002 0.835
202210 1.292 125.734 1.337
202301 0.687 126.223 0.708
202304 1.047 127.992 1.064
202307 1.474 128.974 1.487
202310 1.382 129.810 1.385
202401 1.233 130.124 1.233

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Agilent Technologies  (FRA:AG8) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Agilent Technologies Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilent Technologies (FRA:AG8) Business Description

Traded in Other Exchanges
Address
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies (FRA:AG8) Headlines

No Headlines